TY - JOUR
T1 - Influential Periods in Longitudinal Clinical Cardiovascular Health Scores
AU - Krefman, Amy E.
AU - Labarthe, Darwin
AU - Greenland, Philip
AU - Pool, Lindsay
AU - Aguayo, Liliana
AU - Juonala, Markus
AU - Kähönen, Mika
AU - Lehtimäki, Terho
AU - Day, R. Sue
AU - Bazzano, Lydia
AU - Muggeo, Vito M.R.
AU - Van Horn, Linda
AU - Liu, Lei
AU - Webber, Larry S.
AU - Pahkala, Katja
AU - Laitinen, Tomi T.
AU - Raitakari, Olli
AU - Lloyd-Jones, Donald M.
AU - Allen, Norrina B.
N1 - Publisher Copyright:
© 2021 The Author(s). Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.
PY - 2021/11/1
Y1 - 2021/11/1
N2 - The prevalence of ideal cardiovascular health (CVH) among adults in the United States is low and decreases with age. Our objective was to identify specific age windows when the loss of CVH accelerates, to ascertain preventive opportunities for intervention. Data were pooled from 5 longitudinal cohorts (Project Heartbeat!, Cardiovascular Risk in Young Finns Study, The Bogalusa Heart Study, Coronary Artery Risk Development in Young Adults, Special Turku Coronary Risk Factor Intervention Project) from the United States and Finland from 1973 to 2012. Individuals with clinical CVH factors (i.e., body mass index, blood pressure, cholesterol, blood glucose) measured from ages 8 to 55 years were included. These factors were categorized and summed into a clinical CVH score ranging from 0 (worst) to 8 (best). Adjusted, segmented, linear mixed models were used to estimate the change in CVH over time. Among the 18,343 participants, 9,461 (52%) were female and 12,346 (67%) were White. The baseline mean (standard deviation) clinical CVH score was 6.9 (1.2) at an average age of 17.6 (8.1) years. Two inflection points were estimated: At 16.9 years (95% confidence interval: 16.4, 17.4) and at 37.2 years (95% confidence interval: 32.4, 41.9). Late adolescence and early middle age appear to be influential periods during which the loss of CVH accelerates.
AB - The prevalence of ideal cardiovascular health (CVH) among adults in the United States is low and decreases with age. Our objective was to identify specific age windows when the loss of CVH accelerates, to ascertain preventive opportunities for intervention. Data were pooled from 5 longitudinal cohorts (Project Heartbeat!, Cardiovascular Risk in Young Finns Study, The Bogalusa Heart Study, Coronary Artery Risk Development in Young Adults, Special Turku Coronary Risk Factor Intervention Project) from the United States and Finland from 1973 to 2012. Individuals with clinical CVH factors (i.e., body mass index, blood pressure, cholesterol, blood glucose) measured from ages 8 to 55 years were included. These factors were categorized and summed into a clinical CVH score ranging from 0 (worst) to 8 (best). Adjusted, segmented, linear mixed models were used to estimate the change in CVH over time. Among the 18,343 participants, 9,461 (52%) were female and 12,346 (67%) were White. The baseline mean (standard deviation) clinical CVH score was 6.9 (1.2) at an average age of 17.6 (8.1) years. Two inflection points were estimated: At 16.9 years (95% confidence interval: 16.4, 17.4) and at 37.2 years (95% confidence interval: 32.4, 41.9). Late adolescence and early middle age appear to be influential periods during which the loss of CVH accelerates.
KW - adolescence
KW - cardiovascular epidemiology
KW - cardiovascular health
KW - cohort studies
KW - longitudinal studies
KW - prevention
KW - risk factors
UR - http://www.scopus.com/inward/record.url?scp=85121406381&partnerID=8YFLogxK
U2 - 10.1093/aje/kwab149
DO - 10.1093/aje/kwab149
M3 - Article
C2 - 34010956
AN - SCOPUS:85121406381
SN - 0002-9262
VL - 190
SP - 2384
EP - 2394
JO - American journal of epidemiology
JF - American journal of epidemiology
IS - 11
ER -